To mimic the activation of HIF-1, type 2 diabetic patients living at high altitude, La Paz, Bolivia (3600 m above sea level, masl), were included together with a corresponding patient group living at low altitude, Stockholm, Sweden (28 masl), serving as controls. Here, HIF1A is linked to type 2 diabetes mellitus.